Who makes three doses of PCV13a vaccine?

three doses of PCV13a vaccine is developed by Beijing Chaoyang District Centre for Disease Control and Prevention.

What development phase is three doses of PCV13a vaccine in?

three doses of PCV13a vaccine is in Phase 1.

Last reviewed 2026-05-13 · How we verify

three doses of PCV13a vaccine

Beijing Chaoyang District Centre for Disease Control and Prevention · Phase 1 active Biologic

At a glance

Generic name	three doses of PCV13a vaccine
Sponsor	Beijing Chaoyang District Centre for Disease Control and Prevention
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

three doses of PCV13a vaccine CI brief — competitive landscape report
three doses of PCV13a vaccine updates RSS · CI watch RSS
Beijing Chaoyang District Centre for Disease Control and Prevention portfolio CI